Interleukin-8 expression is regulated by histone deacetylases through the nuclear factor-κB pathway in breast cancer

Molecular Pharmacology

Volumn 74, Issue 5, 2008, Pages 1359-1366

  Chavey, Carine ^a   Mühlbauer, Marcus ^b   Bossard, Carine ^a   Freund, Ariane ^a   Durand, Sébastien ^a   Jorgensen, Christian ^a   Jobin, Christian ^b   Lazennec, Gwendal ^a,c  

^a INSERM   (France)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UMR 9004 Centre national de la recherche scientifique   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE; I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; SYNAPTOTAGMIN I; TRICHOSTATIN A;

ARTICLE; BREAST CANCER; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HISTONE DEACETYLASES; HUMANS; INTERLEUKIN-8; NF-KAPPA B; PROMOTER REGIONS (GENETICS); RECOMBINATION, GENETIC; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 54349115394     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.047332     Document Type: Article

References (42)

1. Adam E, Quivy V, Bex F, Chariot A, Collette Y, Vanhulle C, Schoonbroodt S, Goffin V, Nguyên TL, Gloire G, Carrard G, Friguet B, De Launoit Y, Burny A, Bours V, Piette J, and Van Lint C (2003) Potentiation of tumor necrosis factor-induced NF-κB activation by deacetylase inhibitors is associated with a delayed cytoplasmic reappearance of IκBκ. Mol Cell Biol 23:6200-6209.
2. Ali S and Lazennec G (2007) Chemokines: novel targets for breast cancer metastasis. Cancer Metastasis Rev 26:401-420.
3. Anest V, Hanson JL, Cogswell PC, Steinbrecher KA, Strahl BD, and Baldwin AS (2003) A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature 423:659-663.
4. Ashburner BP, Westerheide SD, and Baldwin AS Jr (2001) The p65 (RelA) subunit of NF-kappaB interacts with the histone deacetylase (HDAC) corepressors HDAC1 and HDAC2 to negatively regulate gene expression. Mol Cell Biol 21:7065-7077.
5. Bièche I, Chavey C, Andrieu C, Busson M, Vacher S, Le Corre L, Guinebretière JM, Burlinchon S, Lidereau R, and Lazennec G (2007) CXC chemokines located in the 4q21 region are up-regulated in breast cancer. Endocr Relat Cancer 14:1039-1052.
6. Böcker U, Nebe T, Herweck F, Holt L, Panja A, Jobin C, Rossol S, Sartor BR, and Singer MV (2003) Butyrate modulates intestinal epithelial cell-mediated neutrophil migration. Clin Exp Immunol 131:53-60.
7. Chavey C, Bibeau F, Gourgou-Bourgade S, Burlinchon S, Boissière F, Laune D, Roques S, and Lazennec G (2007) Estrogen-receptor negative breast cancers exhibit a high cytokine content. Breast Cancer Res 9:R15.
8. Chen L, Fischle W, Verdin E, and Greene WC (2001) Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293:1653-1657.
9. Duong V, Licznar A, Margueron R, Boulle N, Busson M, Lacroix M, Katzenellenbogen BS, Cavaillès V, and Lazennec G (2006) ERalpha and ERbeta expression and transcriptional activity are differentially regulated by HDAC inhibitors. Oncogene 25:1799-1806.
10. Freund A, Chauveau C, Brouillet JP, Lucas A, Lacroix M, Licznar A, Vignon F, and Lazennec G (2003) IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells. Oncogene 22:256-265.
11. Freund A, Jolivel V, Durand S, Kersual N, Chalbos D, Chavey C, Vignon F, and Lazennec G (2004) Mechanisms underlying differential expression of interleukin-8 in breast cancer cells. Oncogene 23:6105-6114.
12. Gilmour PS, Rahman I, Donaldson K, and MacNee W (2003) Histone acetylation regulates epithelial IL-8 release mediated by oxidative stress from environmental particles. Am J Physiol Lung Cell Mol Physiol 284:L533-L540.
13. Glozak MA and Seto E (2007) Histone deacetylases and cancer. Oncogene 26:5420-5432.
14. Haller D, Russo MP, Sartor RB, and Jobin C (2002) IKKβ and phosphatidylinositol 3-kinase/Akt participate in non-pathogenic Gram-negative enteric bacteriainduced RelA phosphorylation and NF-κB activation in both primary and intestinal epithelial cell lines. J Biol Chem 277:38168-38178.
15. He TC, Zhou S, da Costa LT, Yu J, Kinzler KW, and Vogelstein B (1998) A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 95: 2509-2514.
16. Hoshimoto A, Suzuki Y, Katsuno T, Nakajima H, and Saito Y (2002) Caprylic acid and medium-chain triglycerides inhibit IL-8 gene transcription in Caco-2 cells: comparison with the potent histone deacetylase inhibitor trichostatin A. Br J Pharmacol 136:280-286.
17. Ito K, Lim S, Caramori G, Chung KF, Barnes PJ, and Adcock IM (2001) Cigarette smoking reduces histone deacetylase 2 expression, enhances cytokine expression, and inhibits glucocorticoid actions in alveolar macrophages. FASEB J 15:1110-1112.
18. Iwata K, Tomita K, Sano H, Fujii Y, Yamasaki A, and Shimizu E (2002) Trichostatin A, a histone deacetylase inhibitor, down-regulates interleukin-12 transcription in SV-40-transformed lung epithelial cells. Cell Immunol 218:26-33.
19. Kuo MH and Allis CD (1998) Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays 20:615-626.
20. Lazennec G, Bresson D, Lucas A, Chauveau C, and Vignon F (2001) ER beta inhibits proliferation and invasion of breast cancer cells. Endocrinology 142:4120-4130.
21. Lazennec G, Kern L, Salbert G, Saligaut D, and Valotaire Y (1996) Cooperation between the human estrogen receptor (ER) and MCF-7 cell-specific transcription factors elicits high activity of an estrogen-inducible enhancer from the trout ER gene promoter. Mol Endocrinol 10:1116-1126.
22. Leoni F, Zaliani A, Bertolini G, Porro G, Pagani P, Pozzi P, Donà G, Fossati G, Sozzani S, Azam T, et al. (2002) The antitumor histone deacetylase inhibitor suberoylanilide hydroxamic acid exhibits antiinflammatory properties via suppression of cytokines. Proc Natl Acad Sci U S A 99:2995-3000.
23. Lin Y, Huang R, Chen L, Li S, Shi Q, Jordan C, and Huang RP (2004) Identification of interleukin-8 as estrogen receptor-regulated factor involved in breast cancer invasion and angiogenesis by protein arrays. Int J Cancer 109:507-515.
24. Lucas A, Kremer EJ, Hemmi S, Luis J, Vignon F, and Lazennec G (2003) Comparative transductions of breast cancer cells by three DNA viruses. Biochem Biophys Res Commun 309:1011-1016.
25. Margueron R, Licznar A, Lazennec G, Vignon F, and Cavaillès V (2003) Oestrogen receptor alpha increases p21(WAF1/CIP1) gene expression and the antiproliferative activity of histone deacetylase inhibitors in human breast cancer cells. J Endocrinol 179:41-53.
26. Marks PA, Richon VM, and Rifkind RA (2000) Histone deacetylase inhibitors: inducers of differentiation or apoptosis of transformed cells. J Natl Cancer Inst 92:1210-1216.
27. Mayo MW, Denlinger CE, Broad RM, Yeung F, Reilly ET, Shi Y, and Jones DR (2003) Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-κB through the Akt pathway. J Biol Chem 278:18980-18989.
28. Moser B, Wolf M, Walz A, and Loetscher P (2004) Chemokines: multiple levels of leukocyte migration control. Trends Immunol 25:75-84.
29. Mühlbauer M, Chilton PM, Mitchell TC, and Jobin C (2008) Impaired Bcl3 upregulation leads to enhanced lipopolysaccharide-induced interleukin (IL)-23P19 gene expression in IL-10(-/-) mice. J Biol Chem 283:14182-14189.
30. Oitzinger W, Hofer-Warbinek R, Schmid JA, Koshelnick Y, Binder BR, and de Martin R (2001) Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli. Blood 97:1611-1617.
31. Rahman I, Gilmour PS, Jimenez LA, and MacNee W (2002) Oxidative stress and TNF-alpha induce histone acetylation and NF-kappaB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem 234-235:239-248.
32. Rasheed WK, Johnstone RW, and Prince HM (2007) Histone deacetylase inhibitors in cancer therapy. Expert Opin Investig Drugs 16:659-678.
33. Russo MP, Bennett BL, Manning AM, Brenner DA, and Jobin C (2002) Differential requirement for NF-kappaB-inducing kinase in the induction of NF-kappaB by IL-1beta, TNF-alpha, and Fas. Am J Physiol Cell Physiol 283:C347-C357.
34. Timmermann S, Lehrmann H, Polesskaya A, and Harel-Bellan A (2001) Histone acetylation and disease. Cell Mol Life Sci 58:728-736.
35. Tomita K, Barnes PJ, and Adcock IM (2003) The effect of oxidative stress on histone acetylation and IL-8 release. Biochem Biophys Res Commun 301:572-577.
36. Wade PA (2001) Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Hum Mol Genet 10:693-698.
37. Wen X and Wu GD (2001) Evidence for epigenetic mechanisms that silence both basal and immune-stimulated transcription of the IL-8 gene. J Immunol 166:7290-7299.
38. Wu C (1997) Chromatin remodeling and the control of gene expression. J Biol Chem 272:28171-28174.
39. Yamamoto Y, Verma UN, Prajapati S, Kwak YT, and Gaynor RB (2003) Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature 423:655-659.
40. Yang XJ and Seto E (2007) HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26:5310-5318.
41. Yao C, Lin Y, Chua MS, Ye CS, Bi J, Li W, Zhu YF, and Wang SM (2007) Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells. Int J Cancer 121:1949-1957.
42. Zhong H, May MJ, Jimi E, and Ghosh S (2002) The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol Cell 9:625-636.